- Home
- PFE vs BMO Comparison
PFE vs BMO Comparison
Compare PFE & BMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFE | BMO |
|---|---|---|
| Founded | 1849 | 1817 |
| Country | United States | Canada |
| Employees | N/A | 53000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 113.4B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PFE | BMO |
|---|---|---|
| Price | $25.12 | $171.60 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | $29.29 | ★ $163.00 |
| AVG Volume (30 Days) | ★ 25.0M | 588.3K |
| Earning Date | 05-05-2026 | 05-27-2026 |
| Dividend Yield | ★ 6.55% | 3.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $62,579,000,000.00 | N/A |
| Revenue This Year | N/A | $19.43 |
| Revenue Next Year | N/A | $4.27 |
| P/E Ratio | $55.29 | ★ $17.46 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.11 | $105.04 |
| 52 Week High | $28.75 | $171.69 |
Technical Indicators
Market Signals| Indicator | PFE | BMO |
|---|---|---|
| Relative Strength Index (RSI) | 38.00 | 76.08 |
| Support Level | $25.06 | $122.60 |
| Resistance Level | $26.41 | N/A |
| Average True Range (ATR) | 0.45 | 2.91 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 6.89 | 90.10 |
Price Performance
Historical ComparisonAbout PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About BMO Bank Of Montreal
Bank of Montreal is a diversified financial services provider based in North America with over CAD 1.47 trillion in assets by the end of fiscal 2025. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the US.